IL33 and breast neoplasm: In patients with ER-positive breast tumors, the serum levels of IL-33 were 39.92 ± 13.97 pg/ml, and were significantly higher than in patients with ER-negative tumors, which were 32.79 ± 10.84 pg/ml, p = 0.033 (Table 1).